| n (%) or mean ± SD (range) |
---|---|
Age (years) (n = 68) | |
 Mean | 55.7 ± 14.7 (20–87) |
Sex (male/female), (male %) (n = 68) | 15:19 (44%) |
Symptoms (n = 68) | |
 Asymptomatic | 23 (34%) |
Symptoms | |
 Abdominal pain | 34 (50%) |
 Weight loss | 12 (18%) |
 Nausea/vomiting | 6 (8.8%) |
 Dyspepsia | 5 (7.4%) |
 Back pain | 4 (5.9%) |
 Abdominal mass | 3 (4.4%) |
 Anemia | 2 (2.9%) |
 Melena | 2 (2.9%) |
 Jaundice | 2 (2.9%) |
Mean size (cm) (n = 64) | 6.1 ± 5.7 (1–33) |
Location (n = 67) | |
 Uncinate | 9 (13%) |
 Head | 27 (40%) |
 Head + body | 3 (4.5%) |
 Body | 14 (21%) |
 Body + tail | 7 (10%) |
 Tail | 6 (9.0%) |
Nature of tumor on imaging (n = 68) | |
 Solid | 19 (28%) |
 Cystic | 29 (43%) |
 Solid + cystic | 15 (22%) |
 Not specified | 5 (7.4%) |
Imaging characteristics | |
 Well-defined margins (n = 59) | 47 (80%) |
 Presence of calcifications (n = 58) | 5 (8.6%) |
 Pancreatic duct/CBD dilation (n = 22) | 2 (9.1%) |
Relation to nearby structures (n = 29) | |
 No changes to nearby structures | 12 (41%) |
 Compressed/displaced vessels | 9 (31%) |
 Encasement of vessels | 4 (14%) |
 Invasion of viscera | 3 (10%) |
Preoperative diagnosis (n = 44) | |
 Correct | 9 (20%) |
 Incorrect | 35 (80%) |
 Cystic neoplasm | 17 (49%) |
 Serous cystic neoplasm | 3 (8.6%) |
 Mucinous cystic neoplasm | 8 (23%) |
 Solid pseudopapillary neoplasm | 7 (20%) |
 Pancreatic neuroendocrine tumor | 8 (23%) |
 Pseudocyst | 2 (5.7%) |
 Acinar cell carcinoma | 3 (8.6%) |
 Mucinous cystadenocarcinoma | 6 (17%) |
Treatment (n = 67) | |
 Pancreaticoduodenectomy | 16 (24%) |
 Pylorus-preserving pancreaticoduodenectomy | 7 (10%) |
 Central pancreatectomy | 2 (3.0%) |
 Distal pancreatectomy +/− splenectomy | 15 (22%) |
 Enucleation | 8 (12%) |
 Surgical resection not otherwise specified (NOS) | 14 (21%) |
 Unresectable | 2 (3.0%) |
 Refused | 3 (4.5%) |
Histology (n = 68) | |
 Benign | 60 (88%) |
 Malignant | 8 (12%) |
Mean follow-up (months) (n = 34) | 19 ± 15.4 (3–65) |
Died of disease | 1 |